| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0959-8049(98)00190-7 |
| P698 | PubMed publication ID | 9893669 |
| P50 | author | Maurizio D'Incalci | Q42876004 |
| P2093 | author name string | G Guidi | |
| G Damia | |||
| P2860 | cites work | Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease | Q24310295 |
| RPA involvement in the damage-recognition and incision steps of nucleotide excision repair | Q24312764 | ||
| Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease | Q24321351 | ||
| Human DNA repair excision nuclease. Analysis of the roles of the subunits involved in dual incisions by using anti-XPG and anti-ERCC1 antibodies | Q24336495 | ||
| XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes | Q24547630 | ||
| An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair | Q24651193 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein | Q28292405 | ||
| DNA excision repair | Q29618453 | ||
| Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy | Q34229177 | ||
| Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair | Q34724045 | ||
| 3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines. | Q36134289 | ||
| An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells | Q36566743 | ||
| DNA repair protein XPA binds replication protein A (RPA). | Q36718103 | ||
| Reaction mechanism of human DNA repair excision nuclease | Q38359257 | ||
| Human nucleotide excision repair syndromes: molecular clues to unexpected intricacies | Q40515675 | ||
| Cisplatin and DNA repair in cancer chemotherapy | Q40930064 | ||
| DNA damage and cell cycle checkpoints | Q40993748 | ||
| DNA repair and transcription | Q41044019 | ||
| TFIIH: a key component in multiple DNA transactions | Q41099885 | ||
| Relationships between DNA repair and transcription | Q41114776 | ||
| DNA repair in eukaryotes | Q41114782 | ||
| DNA repair: enzymatic mechanisms and relevance to drug response | Q41127626 | ||
| Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line | Q41174585 | ||
| Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents. | Q41192356 | ||
| Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*). | Q41252834 | ||
| Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3. | Q41524479 | ||
| ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients | Q41599173 | ||
| O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines | Q42371298 | ||
| Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. | Q45924161 | ||
| Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. | Q50586207 | ||
| hMLH1 and hMSH2 expression and BAX frameshift mutations in ovarian cancer cell lines and tumors. | Q53434338 | ||
| DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance | Q56981144 | ||
| Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent | Q71191762 | ||
| Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents | Q71567325 | ||
| Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer | Q73224544 | ||
| P433 | issue | 11 | |
| P921 | main subject | cisplatin | Q412415 |
| P304 | page(s) | 1783-1788 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines | |
| P478 | volume | 34 |
| Q24811443 | ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines |
| Q31853437 | An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin |
| Q36610915 | Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil. |
| Q58791244 | Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk |
| Q34534850 | DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells |
| Q33578400 | Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin |
| Q60673355 | Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma |
| Q33659502 | Functional evaluation of DNA repair in human biopsies and their relation to other cellular biomarkers |
| Q40899932 | Functions of yeast helicase Ssl2p that are essential for viability are also involved in protection from the toxicity of adriamycin. |
| Q73807233 | Genetic variability in susceptibility and response to toxicants |
| Q36360811 | Metabolism and transport of oxazaphosphorines and the clinical implications |
| Q28572464 | Nucleotide excision repair gene expression in the rat conceptus during organogenesis |
| Q36947492 | Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity |
| Q34569008 | Oxaliplatin: a review of evolving concepts |
| Q44561304 | Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products. |
| Q30760649 | Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. |
| Q34842777 | Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity. |
| Q44164209 | Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expression. |
| Q33952673 | Targeting and processing of site-specific DNA interstrand crosslinks |
| Q36510142 | The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro |
| Q35873673 | Using microarrays to predict resistance to chemotherapy in cancer patients |
Search more.